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Abstract: BACKGROUND: Alzheimer’s disease (AD), which results in cognitive deficits, usually occurs in
older people and is mainly caused by amyloid beta (Aß) deposits and neurofibrillary tangles. The bile acid
receptor, farnesoid X receptor (FXR), has been extensively studied in cardiovascular diseases and digestive
diseases. However, the role of FXR in AD is not yet understood. The purpose of the present study was to
investigate the mechanism of FXR function in AD. MATERIAL AND METHODS: Lentivirus infection,
flow cytometry, real-time PCR, and western blotting were used to detect the gain or loss of FXR in cell
apoptosis induced by Aß. Co-immunoprecipitation was used to analyze the molecular partners involved in
Aß-induced apoptosis. RESULTS: We found that the mRNA and protein expression of FXR was enhanced
in Ab-triggered neuronal apoptosis in differentiated SH-SY5Y cells and in mouse hippocampal neurons.
Overexpression of FXR aggravated Aß-triggered neuronal apoptosis in differentiated SH-SY5Y cells, and
this effect was further increased by treatment with the FXR agonist 6ECDCA. Molecular mechanism
analysis by co-immunoprecipitation and immunoblotting revealed that FXR interacted with the cAMP-
response element-binding protein (CREB), leading to decreased CREB and brain-derived neurotrophic
factor (BDNF) protein levels. Low expression of FXR mostly reversed the Aß-triggered neuronal apoptosis
effect and prevented the reduction in CREB and BDNF. CONCLUSIONS: These data suggest that
FXR regulates Aß-induced neuronal apoptosis, which may be dependent on the CREB/BDNF signaling
pathway in vitro.
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 Background: Alzheimer’s disease (AD), which results in cognitive deficits, usually occurs in older people and is mainly caused 
by amyloid beta (Ab) deposits and neurofibrillary tangles. The bile acid receptor, farnesoid X receptor (FXR), has 
been extensively studied in cardiovascular diseases and digestive diseases. However, the role of FXR in AD is 
not yet understood. The purpose of the present study was to investigate the mechanism of FXR function in AD.
 Material/Methods: Lentivirus infection, flow cytometry, real-time PCR, and western blotting were used to detect the gain or loss 
of FXR in cell apoptosis induced by Ab. Co-immunoprecipitation was used to analyze the molecular partners 
involved in Ab-induced apoptosis.
 Results: We found that the mRNA and protein expression of FXR was enhanced in Ab-triggered neuronal apoptosis in dif-
ferentiated SH-SY5Y cells and in mouse hippocampal neurons. Overexpression of FXR aggravated Ab-triggered 
neuronal apoptosis in differentiated SH-SY5Y cells, and this effect was further increased by treatment with the 
FXR agonist 6ECDCA. Molecular mechanism analysis by co-immunoprecipitation and immunoblotting revealed 
that FXR interacted with the cAMP-response element-binding protein (CREB), leading to decreased CREB and 
brain-derived neurotrophic factor (BDNF) protein levels. Low expression of FXR mostly reversed the Ab-triggered 
neuronal apoptosis effect and prevented the reduction in CREB and BDNF.
 Conclusions: These data suggest that FXR regulates Ab-induced neuronal apoptosis, which may be dependent on the 
CREB/BDNF signaling pathway in vitro.
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Background
Alzheimer’s disease (AD), a chronic neurodegenerative disorder, 
is the most frequent cause of dementia [1–3]. The incidence 
of AD is rising worldwide with increasing age [4]. The primary 
pathological changes in AD are intracellular neurofibrillary tan-
gles induced by tau phosphorylation and intercellular senile 
plaque accumulation induced by oligomerization of the b-amy-
loid (Ab) protein [5,6].
The toxic effects of Ab can lead to dysfunction in neurotrophic 
factor expression. In particular, brain-derived neurotrophic fac-
tor (BDNF) downregulation by Ab may lead to synaptic loss and 
neurodegeneration [7]. Ab-induced BDNF dysfunction is medi-
ated by the cAMP-response element-binding protein (CREB), 
an important transcriptional element necessary for memory 
and for the survival of neurons [8]. CREB expression was de-
creased in post-mortem hippocampus of AD patients, in mouse 
hippocampal neurons, and in Ab-triggered hippocampal neu-
rons and SH-SY5Y cells [9]. The farnesoid X receptor (FXR), 
a nuclear receptor widely expressed in the liver and intestine, 
plays an important role in the synthesis, secretion, and trans-
port of bile acid [10]. The function of CREB can be suppressed 
by activated FXR [11].
FXR was proved to be present and function in the brain [12]. 
We speculated that FXR functions in the progression of AD by 
regulating brain lipid levels. In the present study, FXR func-
tion in AD was analyzed using an Ab1–42-treated neuro-
nal cell model. FXR expression was elevated in differentiated 
SH-SY5Y cells and in mouse hippocampal neurons treated 
with Ab1–42. FXR potentiated Ab1–42-triggered cell apopto-
sis in parallel with decreased expression of CREB. In addition, 
the CREB/BDNF signaling pathway was inhibited by FXR over-
expression and promoted by FXR knockdown. From these data, 
we speculate that FXR possess an Ab-induced cell apoptosis-
enhancing property by modulating the transcription of CREB 
and downstream BDNF expression.
Material and Methods
Cell culture
Human SH-SY5Y cells were purchased from the American Type 
Culture Collection and were cultured in a 10-cm dish contain-
ing DMEM/F12 medium, 10% FBS, and 1% penicillin/strepto-
mycin (P/S). The maintenance of cells was carried out in a CO
2
 
incubator, and one-half of the medium was changed each day. 
For cell differentiation, 2 × 105 cells were seeded per well in 
6-well plates (Corning) in DMEM/F12, 10% FBS, and 1% P/S 
for 24 h. The medium was then changed to DMEM/F12, 1% 
N-2 supplements, 1% P/S, and 10 μM all-trans retinoic acid. 
After 7-day incubation with RA, Ab1–42 (1 μM) was added and 
the cells were cultured for another 24 h.
Mouse hippocampal neurons derived from neonatal C57BL/6 
mice were cultured as described previously [13]. Briefly, brains 
were removed and the hippocampus was dissected from each 
animal, and tissues were dissociated by mild mechanical trit-
uration. Cells were plated onto poly-D-lysine-coated 6-well 
plates in Neurobasal medium containing 2% B27 and 1% P/S 
in a CO
2
 incubator at 37°C, and one-half of the medium was 
changed each day.
Ab1–42 and 6ECDCA preparation
Ab1–42 peptide (Sigma-Aldrich) was prepared following pre-
viously reported methods [14]. Initially, the Ab1–42 peptide 
was dissolved in 100% hexafluoro isopropanol to a final con-
centration of 1 mM and the suspension was aliquoted into 
sterile microcentrifuge tubes and evaporated under vacuum 
in a Speed-Vac. Oligomerization of Ab1–42 was performed in 
DMSO 5 mM, followed by ultrasound for 10 min. Before use, 
Ab1–42 was diluted to a final concentration of 100 μM in 
DMEM at 4°C for 24 h.
6ECDCA was dissolved in 100% ethanol to a final concen-
tration of 1 mM as reported previously [15], and stored at 
–20°C. The cells were stimulated with 6ECDCA (2 μM) for 
24 h, followed by incubation with or without Ab1–42 (1 μM) 
for another 24 h. The effects of forskolin treatment were de-
termined by incubating FXR-overexpressed cells with or with-
out forskolin (10 μM) for 1 h.
Lentiviral transduction
All lentiviral products with enhanced green fluorescence 
protein (EGFP)-tags used in this study were supplied by 
Genechem (Shanghai, China). The titers for lentiviral (LV)-FXR 
and LV-Control were adjusted to 5×108 TU/ml, and the titers 
for LV-FXR-short hairpin (sh)RNA and LV-Scrambled-shRNA 
were adjusted to 8×108 TU/ml. The sequences for FXR-shRNA 
and control shRNA were 5’-CCACTTCTTGATGTGCTACAA-3’ and 
5’-TTCTCCGAACGTGTCACGT-3’, respectively. To select effec-
tive shRNA sequences targeting FXR, lentivirus encoding trial 
shRNA sequences were transduced SH-SY5Y cells at a multi-
plicity of infection (MOI) of 5; after culturing for 3 days, cells 
were selected for 4 days in medium containing 0.6 μg/ml puro-
mycin (Sigma-Aldrich). The upregulation and suppression of 
mRNA expression were analyzed by real-time PCR, and FXR 
protein levels were detected using immunoblotting.
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RNA extraction and real-time PCR
Briefly, total RNA was isolated from SH-SY5Y cells using TRIzol® 
reagent (Thermo Fisher, DE, USA). The PrimeScript™ RT Master 
Mix was then used for reverse transcription and SYBR® fast 
qPCR master mix was used for real-time PCR following the kit 
protocols. The primers used are shown in Table 1. The rela-
tive gene expression was calculated using the 2–DDCt method.
Co-immunoprecipitation and immunoblotting
Cells were extracted in RIPA buffer, and immunoprecipitation 
with specific antibodies was performed using protein A agarose. 
The pellets were washed 3 times. Immunoblotting was then per-
formed with diluted antibodies overnight at 4°C or for 2 h at room 
temperature using a standard procedure [16,17]. The primary 
antibodies included: anti-FXR (#sc-25309, 1: 750, Santa Cruz), 
anti-CREB (#9192, 1: 1000, Cell Signaling Technology), anti-
proBDNF (#sc-65514, 1: 750, Santa Cruz), anti-Bax (#ab182733, 
1: 500, Abcam), anti-Bcl-2 (#ab32124, 1: 500, Abcam), and anti-
b-actin (#A1978, 1: 1000, Sigma-Aldrich). To confirm reproduc-
ibility, experiments were performed at least 3 times. Band in-
tensity quantification was carried out using Image J software.
Cell apoptosis analysis
The apoptosis of cells was measured with a PE-AnnexinV 
apoptosis detection kit (BD Biosciences, Franklin Lakes, NJ, 
USA). Briefly, after 3 washes with PBS, SH-SY5Y cells infected 
with lentivirus were resuspended in 1×binding buffer (100 µl). 
PE-AnnexinV (5 μl) and 7-AAD (5 μl) were then added to the 
cell suspension and incubated for 15 min at room tempera-
ture. The cells were sorted using a FACS Calibur flow cytome-
ter (BD Biosciences). Data from EGFP+cells were collected and 
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Statistical analysis
Experiments were performed using 3 different batches of cells 
and each batch was tested in duplicate. Statistical analysis was 
performed with GraphPad Prism 6.0 (GraphPad Software, Inc., 
La Jolla, CA, USA). Two-way analysis of variance followed by 
Dunnett’s post hoc test for multiple comparisons was used for 
comparisons, and data are presented as mean±SEM. * p<0.05, 
** p<0.01, *** p<0.0001 were considered statistically significant.
Results
FXR was upregulated in Ab1–42-induced cell apoptosis
Low concentrations of Ab1–42 are directly toxic to neuro-
nal cells [18]. FXR expression in Ab1–42-induced cell apopto-
sis was evaluated. The mRNA and protein expressions of FXR 
were significantly enhanced following treatment with Ab1–42 
in mouse hippocampal neuronal cells (Figure 1A, 1B) and in 
SH-SY5Y cells (Figure 1C, 1D). In addition, immunoblotting 
of markers for Ab1–42-induced apoptosis showed that Bcl-2 
Figure 1.  FXR is involved in Ab-triggered apoptosis in mouse hippocampal neurons and SH-SY5Y cells. (A) Mouse hippocampal 
neuronal cells were treated with Ab1–42 (1 μM) for 24 h. Cells were harvested and FXR mRNA was measured by real-
time PCR. GAPDH was used to normalize the FXR mRNA expression. * p<0.05 compared with the control group. (B) Mouse 
hippocampal neuronal cells were treated with Ab1–42 (1 μM) for 24 h. Cells were harvested and protein level of FXR 
was measured by immunoblotting (left panel). Quantification of FXR protein band (right panel). Protein expression was 
normalized to b-actin. * p<0.05 compared with the control group, and data are shown as mean±SEM. (C) SH-SY5Y cells were 
pretreated with or without 6ECDCA (2 μM) for 24 h and then stimulated with Ab1–42 (1 μM) for 24 h. After incubation, 
cells were harvested and FXR mRNA was measured by real-time PCR. GAPDH was used to normalize FXR mRNA expression. 
* p<0.05 compared with the control group. (D) SH-SY5Y cells were pretreated with or without 6ECDCA (2 μM) for 24 h and 
then stimulated with Ab1–42 (1 μM) for another 24 h. After incubation, cells were harvested and protein levels of FXR, Bax, 
and Bcl-2 were measured by immunoblotting (left panel). Quantification of Bax, Bcl2 and FXR protein bands (right panel). 
Protein expression was normalized to b-actin. * p<0.05 compared with the control group, and data are shown as mean±SEM. 
(E) Cells were pretreated with or without 6ECDCA (2 μM) for 24 h and then stimulated with Ab1–42 (1 μM) for another 24 h. 
After incubation, cells were harvested and Annexin V-PE+cells were analyzed by flow cytometry. (F) Quantification of Annexin 
V-PE-stained cells . Experiments were performed using 3 different batches of cells. * p<0.05 compared with the control group, 
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protein expression was decreased, while Bax protein levels 
were significantly increased, indicating that FXR expression is 
related to Ab1–42-induced apoptosis (Figure 1D).
To determine whether FXR plays a role in Ab1–42-triggered apop-
tosis in SH-SY5Y cells, we examined the effect of 6ECDCA, an FXR 
agonist, on Ab-triggered apoptosis. 6ECDCA treatment alone did 
not induce significant apoptosis compared with the negative con-
trol (Figure 1E, 1F). Co-treatment with 6ECDCA resulted in a slight 
increase in FXR mRNA and protein expression (Figure 1C, 1D); 
however, this increase was not significantly different between 
the groups. Ab-induced cell apoptosis was also unchanged after 
6-ECDCA co-treatment, as shown by flow cytometry and immu-
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FXR overexpression aggravates Ab-triggered cell apoptosis
The role of FXR overexpression in Ab-induced SH-SY5Y cell apop-
tosis was determined. FXR overexpression and control lentivi-
ral vectors were generated and transfected into SH-SY5Y cells. 
Two days after transfection, enhanced FXR mRNA and protein 
expression were observed in FXR-EGFP cells (Figure 2A, 2B). 
FXR-EGFP cells were then subjected to Ab1–42 or Ab1–42 
plus 6ECDCA and analyzed by flow cytometry (Figure 2C). 
Compared to the control-EGFP group, a slight increase of apop-
tosis in the absence of Ab1–42 was observed when FXR was 
overexpressed (Figure 2D). Figure 2D also demonstrates that 
6ECDCA did not significantly enhance Ab-induced apoptosis 
in control-EGFP cells, which was consistent with the results in 
Figure 1F. However, compared to the Ab-treated control-EGFP 
cells, FXR overexpression induced an increase in early and late 
(Q2+Q4) apoptosis in the Ab1–42 group. Figure 2E indicates 
that FXR-EGFP cells showed a decrease in Bcl2 expression and 
an increase in Bax expression in the Ab1–42 group, suggesting 
that Ab-induced cell apoptosis was enhanced by FXR overex-
pression. Following 6ECDCA treatment, Ab1–42-induced apop-
tosis was even higher in the Ab1–42+6ECDCA group, indicat-
ing that FXR activation contributes to apoptosis.
FXR overexpression affects Ab-induced apoptosis by 
regulating CREB transcriptional activity and BDNF 
expression
FXR has been proved to interact with CREB in mouse hepa-
tocytes and in intestinal L cells, thus inhibiting its binding to 
the DNA binding site [11]. In the present study, the contribu-
tion of FXR/CREB to Ab-induced apoptosis was determined. 
The FXR and CREB combination in FXR-EGFP cells was con-
firmed. The protein interaction between FXR and CREB was 
detected by immunoblotting with FXR antibody followed by 
immunoprecipitation with CREB antibody (Figure 3A). The com-
bination of FXR and CREB in Ab-treated FXR-EGFP cells was 
also confirmed and compared with the Ab-treated control-EGFP 
cells. The interaction between FXR and CREB increased in 
FXR-EGFP cells following Ab treatment, and further increased 
with Ab1–42+6ECDCA co-treatment (Figure 3B).
Compared to the Ab-treated control-EGFP cells, the expression 
level of CREB decreased in FXR-EGFP cells following Ab1–42 
treatment and further decreased in the Ab1–42+6ECDCA 
group (Figure 3C), suggesting that FXR not only interacted 
with the function and activity of CREB, but also regulated its 
expression. Physiologically, CREB modulates BDNF, which is 
very important in Ab-induced cell apoptosis. BDNF expression 
in FXR-EGFP cells was then examined. Figure 3C shows that 
Figure 2.  FXR overexpression aggravated Ab-triggered cell apoptosis. (A) SH-SY5Y cells were infected with overexpressing lentivirus 
for FXR, and the level of FXR mRNA was assessed by real-time PCR. GAPDH was used to normalize FXR mRNA expression. 
*** p<0.0001, compared with the control-EGFP group. (B) The level of FXR protein was assessed by immunoblotting. 
Quantification of FXR protein band in SH-SY5Y cells (right panel). b-actin was used as an internal control. *** p<0.0001, 
compared with the control-EGFP group. (C) FXR-EGFP cells were pretreated with or without 6ECDCA (2 μM) for 24 h and 
then stimulated with or without Ab1–42 (1 μM) for another 24 h. After incubation, cells were harvested for flow cytometry 
analysis. (D) Annexin V-PE-stained EGFP+cells were regarded as apoptotic cells. * p<0.05, ** p<0.01 compared with the 
Ab-treated control-EGFP cells, and data are shown as mean±SEM. (E) FXR-EGFP cells were pretreated with or without 
6ECDCA (2 μM) for 24 h and then stimulated with Ab1–42 (1 μM) for another 24 h. After incubation, cells were harvested 
and protein levels of Bax and Bcl-2 were measured by immunoblotting (left panel). Quantification of protein bands is shown 
in the right panel. Experiments were performed using 3 different batches of cells. Protein expression was normalized to 
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Figure 3.  FXR overexpression aggravated Ab-induced apoptosis in cells via CREB/BDNF signaling. (A) FXR-EGFP cells were harvested 
and the CREB and FXR interaction was measured by co-immunoprecipitation with the antibodies indicated. (B) FXR-EGFP cells 
were harvested, pretreated with or without 6ECDCA (2 μM) for 24 h and then stimulated with Ab1–42 (1 μM) for another 
24 h. After incubation, cells were harvested and the CREB and FXR interaction was measured by co-immunoprecipitation 
with the antibodies indicated. (C) FXR-EGFP cells were pretreated with or without 6ECDCA (2 μM) for 24 h and then 
stimulated with Ab1–42 (1 μM) for another 24 h. After incubation, cells were harvested and protein levels of CREB and 
BDNF in crude lysates were measured by immunoblotting (left panel). (D) FXR-EGFP cells were pretreated with or without 
6ECDCA (2 μM) for 24 h and then stimulated with Ab1–42 (1 μM) for another 24 h. One hour before harvest, cells were 
treated with or without forskolin (10 μM) and the protein levels of CREB, BDNF, and Bcl2 in crude lysates were measured by 
immunoblotting (left panel). Quantification of protein bands is shown in the right panel. Protein expression was normalized 
to b-actin. Experiments were performed using 3 different batches of cells. * p<0.05, ** p<0.01 compared with the Ab-treated 
control-EGFP cells, and data are shown as mean±SEM.
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FXR overexpression significantly decreased BDNF expression 
following Ab1–42 treatment and was further decreased in the 
Ab1–42+6ECDCA group.
CREB activation induced BDNF expression and downstream anti-
apoptotic protein Bcl2 expression [19]. In the present study, 
Control shRNA FXR shRNA

























































































































































































forskolin, a CREB signaling activator, was used to stimulate FXR-
transfected SH-SY5Y cells. Although CREB protein levels did 
not change significantly, the protein expression levels of both 
BDNF and Bcl2 were markedly increased after treatment with 
forskolin, and the inhibitory effects of FXR on CREB as well as 
BDNF and Bcl2 protein were also partially reversed (Figure 3D). 
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These findings indicated that FXR overexpression promotes 
Ab-induced apoptosis via the CREB-BDNF pathway.
FXR knockdown abolishes Ab-triggered cell apoptosis
To determine whether the FXR/CREB pathway played a role 
in Ab-induced cell apoptosis, FXR-shRNA lentivirus was trans-
fected into SH-SY5Y cells. Two days after transfection, decreased 
FXR mRNA and protein levels were observed in SH-SY5Y 
cells (Figure 4A, 4B). Cells with low expression of FXR were 
then subjected to Ab1–42 and Ab1–42 plus 6ECDCA treat-
ment and analyzed by flow cytometry (Figure 4D). Compared 
to control shRNA-transfected cells, FXR knockdown induced a 
slight decrease of apoptosis in SH-SY5Y cells in the absence of 
Ab1–42 (Figure 4D). Consistent with the results in Figure 1F, 
6ECDCA did not significantly enhance Ab-induced apoptosis in 
scrambled shRNA-transfected cells (Figure 4D). Figure 4D also 
shows that, compared to the Ab-treated scrambled shRNA-
transfected cells, FXR knockdown induced a decrease in apop-
tosis in cells treated with Ab and/or 6ECDCA, revealing a sta-
ble anti-apoptotic effect.
Figure 4E indicates that, compared to the Ab-treated scram-
bled shRNA-transfected cells, FXR knockdown induced Bcl2 
upregulation and Bax downregulation in cells induced with 
Ab and/or 6ECDCA. Low expression of FXR fully reversed the 
Ab-triggered decrease in CREB and BDNF expression in cells 
treated with Ab and/or 6ECDCA (Figure 4E). Collectively, our 
results show that FXR knockdown induced anti-apoptotic ef-
fects in Ab-induced SH-SY5Y cells.
Discussion
FXR has been reported to play important roles in the metabo-
lism of bile acids, lipids, and glucose in the pathogenesis of 
atherosclerosis and in protection of the liver [20]. However, 
the function of FXR in neural system diseases is not well under-
stood, although its expression in neurons has been demon-
strated [12,21,22]. The present study proved that oligomeric 
Ab1–42 enhanced FXR expression in differentiated SH-SY5Y 
cells and in mouse primary hippocampal neuronal cells. It was 
also proved that FXR was involved in Ab1–42-triggered cell 
apoptosis by interacting with the CREB/BDNF pathway in 
SH-SY5Y cells, while low expression of FXR inhibited apopto-
sis in SH-SY5Y cells treated with Ab1–42. This novel mecha-
nism of the FXR/CREB/BDNF axis indicates a potential thera-
peutic target for AD treatment.
Figure 4.  FXR knockdown inhibits Ab-triggered cell apoptosis. (A) LV-shRNA-FXR was transfected into SH-SY5Y cells to achieve 
knockdown of FXR, and the level of FXR mRNA was assessed by real-time PCR. FXR mRNA expression was normalized to 
GAPDH and quantified. ** p<0.01, compared with the control shRNA group. (B) The level of FXR protein was assessed by 
immunoblotting (left panel). Quantification of protein bands is shown in the right panel. Protein expression was normalized 
to b-actin. ** p<0.01, compared with the control shRNA group. (C) LV-shRNA-FXR-transfected SH-SY5Y cells were pretreated 
with or without 6ECDCA (2 μM) for 24 h and then stimulated with or without Ab1–42 (1 μM) for another 24 h. After 
incubation, cells were harvested and analyzed by flow cytometry. (D) Annexin V-PE-stained EGFP+cells were regarded as 
apoptotic cells. * p<0.05 compared with the Ab-treated control shRNA cells, and data are shown as mean±SEM. (E) LV-shRNA-
FXR-transfected cells were pretreated with or without 6ECDCA (2 μM) for 24 h and then stimulated with Ab1–42 (1 μM) for 
another 24 h. After incubation, cells were harvested and the protein levels of Bcl-2, Bax, CREB, and BDNF were measured by 
immunoblotting (left panel). Quantification of protein bands is shown in the right panel. Protein expression was normalized 
to b-actin. Experiments were performed using 3 different batches of cells. * p<0.05 compared with the Ab-treated control 
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In addition to serving as an Ab1–42-treated AD cell model, 
SH-SY5Y neuroblastoma cells have also been used as an exci-
totoxic in vitro model following exposure to high concentrations 
of exogenous glutamate. As these cells express both ionotropic 
and metabotropic receptors, they may be useful in determining 
excitatory amino acid-induced processes due to the expres-
sion of both ionotropic and metabotropic receptors in this cell 
line [23]. SH-SY5Y cells also serve as a model of serotoninergic 
neuronal cells, as they express monoamine oxidase A [24].
Amyloid plaques, neurofibrillary tangles, and synaptic and 
neuron loss are the 3 main neuropathological characteristics 
of AD. AD is believed to be initiated by neural accumulation of 
Ab, which has been reported to activate the apoptosis path-
way [5,25]. In addition, elevated levels of Ab can inhibit the 
expression of neurotrophic factors, such as BDNF, which is a 
synaptic-plasticity regulator involved in neuronal apoptosis, 
neuron regeneration, and memory and cognitive functions in 
the pathological cascade of AD [26,27]. As a positive regula-
tor of Bcl-2, CREB plays important roles in Ab-induced neu-
ronal apoptosis [19,28]. Therefore, the novel molecules that 
mediate downregulation of CREB caused by Ab could be tar-
gets for drug development in the treatment of AD. It is known 
that Bim and Bax play important roles in matrix metallopro-
teinase, caspase-3 and Bax activation, and the intrinsic apop-
totic pathway. Forkhead box O factors are closely related to the 
PI3K/Akt pathway [29]. The possible involvement of these apop-
totic factors in FXR-mediated Ab-induced apoptosis should be 
considered. FXR was shown to be expressed in the brain, and 
may regulate the brain lipid levels in neurological diseases [12]. 
In a previous study, FXR was elevated in rats with chronic un-
predictable mild stress-induced depression [21]. In addition, 
z-guggulsterone, an FXR antagonist, inhibited the inflamma-
tory responses mediated by microglia in the brain [30]. In the 
present study, we proved that FXR was induced by Ab1–42, 
while endogenous FXR expression was low in SH-SY5Y cells, 
and activated FXR following 6ECDCA treatment did not affect 
Ab-induced cell apoptosis. FXR overexpression has a slight ef-
fect on apoptosis in SH-SY5Y cells in the absence of Ab1–42 
treatment, while FXR overexpression promoted neuronal apop-
tosis triggered by Ab1–42 treatment, and 6ECDCA treatment 
further aggravated Ab-triggered apoptosis in cells with FXR 
overexpression. It is speculated that when overexpressed, FXR 
potentiates Ab-triggered apoptosis, and 6ECDCA stimulation 
further enhances Ab-induced apoptosis in FXR-overexpressed 
cells. Knockdown of FXR inhibited both basal and Ab1–42-
triggered neuronal apoptosis.
Various mechanisms for FXR-mediated regulation of the 
CREB-BDNF pathway have been reported previously. FXR may 
reduce the lipid levels in the brain, as it was shown that hyper-
lipidemic and hypercholesterolemic status decreased BDNF ex-
pression [31,32]. Z-guggulsterone attenuated symptoms in a 
scopolamine-lesioned AD mouse model by augmentation of 
the CREB-BDNF signal, while the direct interaction of FXR and 
CREB was not mentioned in this report [22]. It has been reported 
that oligomeric Ab can reduce CREB expression and phosphor-
ylation, and subsequent BDNF expression [7]. In the present 
study, we found that FXR directly interacted with CREB and 
suppressed its expression and transcriptional activity, leading 
to reduced BDNF expression. The Ab-stimulated CREB-BDNF 
pathway and 6ECDCA-ativated FXR pathway might crosstalk 
with each other. As shown in Figure 5, we speculate that oligo-
meric Ab suppresses CREB activity and subsequent BDNF ex-
pression, partially through upregulating FXR in Ab-induced cell 
apoptosis. However, FXR overexpression-induced increase in 
neuronal apoptosis in the Ab group might not mean a possible 
treatment option for AD, as different neuronal proteins are in-
volved in neuropathological changes of AD (amyloid plaques, 











Figure 5.  (A, B) Scheme of FXR-mediated 
Ab-triggered neuronal cell apoptosis. 
Oligomeric Ab upregulated FXR, 
promoted the interaction of FXR 
and CREB, suppressed CREB activity 
and subsequent BDNF expression, 
disturbed mitochondrial function, 
and then caused cell apoptosis. 
FXR-shRNA inhibited the interaction 
of FXR and CREB, and reversed 
Ab-induced cell apoptosis by 
enhancing CREB and BDNF production 
and restoring mitochondrial function. 
The activator of CREB, forskolin, also 
impeded Ab-induced cell apoptosis 
and mitochondrial dysfunction 
by enhancing CREB activity and 
subsequent BDNF production.
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the pathogenic relationships among them are unclear. As hy-
pothesized based on the amyloid cascade, Ab deposition may 
be the initial event in AD, and may initiate the process of neu-
ronal apoptosis, while the Braak staging of neurofibrillary de-
generation correlates better with the severity of dementia 
compared to the density of neuritic plaques. Moreover, neu-
rofibrillary tangles also represent a mechanism of neuronal 
death independent of apoptosis.
Conclusions
Collectively, from these results, we speculate that FXR possess 
an Ab-induced cell apoptosis-enhancing property in vitro by 
attenuating CREB and BDNF expression.
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